Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors

Three series of novel Nutlin analogs were designed, synthesized as p53-MDM2 binding inhibitors. Compound 7c showed a promising inhibitory activity and induced cell cycle arrest in A549 cells.